Förstl, H
[Symptomatic therapy of Alzheimer dementia].
Wien Med Wochenschr
2002
152
3-4
77-80

Diehl, J;Grimmer, T;Förstl, H;Kurz, A;Drzezga, A;Schwaiger, M
Association of apathy with cerebral glucose metabolism in frontotemporal dementia
Neurobiol Aging
2002
23 Suppl.
1
233 -

Grimmer, T;Diehl, J;Förstl, H;Kurz, A;Drzezga, A;Schwaiger, M
Decline of cerebral glucose metabolism in patients with frontotemporal dementia a follow-up study
Neurobiol Aging
2002
23 Suppl.
1
1709 -

Grimmer, T;Diehl, J;Kurz, A;Förstl, H;Schwaiger, M;Drzezga, A
Region-specific association between cerebral glucose uptake and cognitive performance in patients with frontotemporal dementia.
J Nucl Med
2002
43 Suppl.
5
990 -

Drzezga, A;Grimmer, T;Wermke, M;Storp, C;Förstl, H;Schwaiger, M;Kurz, A
Cerebral activation during navigation in a virtual reality environment. A parametric study using (H2O)-O-15-PET.
J Nucl Med
2002
43 Suppl.
5
1020 -

Drzezga, A;Grimmer, T;Siebner, H;Minoshima, S;Schwaiger, M;Kurz, A
Prominent hypometabolism of the right temporoparietal and frontal cortex in two left-handed patients with primary progressive aphasia.
J Neurol
2002
249
9
1263-7

Diehl, J;Kurz, A
Update on vascular dementias
Aktuelle Neurologie
2002
29
10
483-489

Lilienfeld, S;Kurz, A
Broad therapeutic benefits in patients with probable vascular dementia or Alzheimer's disease with cerebrovascular disease treated with galantamine.
Ann N Y Acad Sci
2002
977
487-92

Kurz, A
A novel treatment for patients with Alzheimer's disease and with vascular dementia.
Ann N Y Acad Sci
2002
977
476-81

Leucht, S;McGrath, J;White, P;Kissling, W
Carbamazepine augmentation for schizophrenia: how good is the evidence?
J Clin Psychiatry
2002
63
3
218-24